Column

Intestinal bacteria contribute to the success of immunotherapy

Despite the success of cancer immunotherapy in some patients, others do not respond at all to its treatments and succumb to their disease. According to a recent study, these interindividual variations are caused by differences in the nature of the intestinal bacteria present in patients. Download the column

Share this content!

Recent Articles

Column Archives

Column Keywords

aging agriculture alcohol alzheimer anthocyanins antibiotics antibodies antioxydants appetite autoimmune disease bacteria basic science berries bladder blood blood vessels bone brain breast cachexia calories cancer cannabis cardiovascular disease chemotherapy children chocolate cholesterol chronic diseases cigarette coffee colon coronavirus COVID-19 Crohn's disease crucifers cytokine dementia diabetes diagnostic diet digestive system drugs dyes eczema embolism endometrium environment epigenetics eyes fasting fat fatigue female cancers fermentation fibers fish food fruit garlic gene therapy genetics hair hearing heart heat high blood pressure immunity immunotherapy inactivity infertility inflammation interferon intestine irradiation junk food kidney larynx leukemia lifestyle liver lung lyme lymphocytes male cancers Mediterranean diet medulloblastoma melanoma memory menopause metabolism metastasis metastasis microbiome mouth multiple sclerosis muscles nausea nervous system neurons nitrites nuts obesity oesophagus olive oil omega-3 oncogenic ovaries pain pancreas parkinson patient care physical activity physical exercise plants plastic polyphenol prebiotics pregnancy prevention probiotics processed food prostate recurrence red meat red wine salt skin sleep smell soy spices stem cells stomach stress sugar sun supplements sweat taste tea testicles therapy thrombosis thyroid tobacco turmeric uterus UV rays vaccines vaping veganism vegetable vegetarianism virus vision vitamin C vitamin D vitamin E weight women yogurt